Investigational weight-loss drug Retatrutide may be more effective than Ozempic
Eli Lily’s new experimental weight loss drug is showing promise. Retatrutide, which just completed a Phase 2 clinical study, helped patients lose an average of 24% of their body weight. The drug improves on existing weight-loss drugs like Wegovy. Weight-loss drugs like Wegovy, Mounjaro and the type 2 diabetes drug Ozempic have been all over … Read more